ARTEMISMED Artemis Medicare Services Q2 FY27 results (Jul–Sep 2026) and concall
Artemis grew Q2 FY27 revenue 13.2% YoY to ₹311 crores, helped by complex specialties and a record 23.8% EBITDA margin at the Gurgaon hospital. Consolidated EBITDA margin was 20.2%, and PAT grew only 3.7% because the new 300-bed Raipur hospital lost about ₹9 crores in its first partial quarter. Management says Raipur's costs are largely already in place and keeps its 12-15 month breakeven target; occupancy is expected to rise to 20-30% in coming quarters. The growth pipeline is Tower 4 at Gurugram (250 beds by H2 FY28), the 650+ bed South Delhi project (Q4 FY29-30), and a fundraise for acquisit
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q2 FY27: revenue down 7.1%, net profit up 3.3% against the same quarter last year.
| Line item | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | Q2 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 6 | 7 | 14 | 14 | 17 +183% | 16 +129% | 13 −7% | 13 −7% |
| EBITDA | 37 | 36 | 41 | 51 | 45 +22% | 52 +44% | 56 +37% | 55 +8% |
| Net profit | 21 | 23 | 21 | 30 | 22 +5% | 30 +30% | 31 +48% | 31 +3% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
